Tenax Therapeutics (TENX) EPS (Basic): 2011-2024
Historic EPS (Basic) for Tenax Therapeutics (TENX) over the last 11 years, with Dec 2024 value amounting to -$1.15.
- Tenax Therapeutics' EPS (Basic) rose 99.99% to -$1.20 in Q4 2016 from the same period last year, while for Dec 2016 it was -$13,771, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$1.15 for FY2024, which is 96.30% up from last year.
- Latest data reveals that Tenax Therapeutics reported EPS (Basic) of -$1.15 as of FY2024, which was up 96.30% from -$31.04 recorded in FY2023.
- Tenax Therapeutics' 5-year EPS (Basic) high stood at $395.50 for FY2022, and its period low was -$31.04 during FY2023.
- For the 3-year period, Tenax Therapeutics' EPS (Basic) averaged around $121.10, with its median value being -$1.15 (2024).
- Per our database at Business Quant, Tenax Therapeutics' EPS (Basic) slumped by 107.85% in 2023 and then skyrocketed by 96.30% in 2024.
- Tenax Therapeutics' EPS (Basic) (Yearly) stood at -$0.95 in 2020, then reached $395.50 in 2022, then plummeted by 107.85% to -$31.04 in 2023, then soared by 96.30% to -$1.15 in 2024.